{"SLR NAME":"Incidence and prognostic associations of myocardial injury in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","References":[{"title1":"Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","References":[]},{"title2":"Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China [published online March 25, 2020].","References":[]}]},{"title1":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Coronavirus disease 2019 (covid-19) in Italy","References":[{"title3":"Coronavirus%20disease%202019%20(covid-19)%20in%20Italy"},{"title3":"Coronavirus%20disease%202019%20(covid-19)%20in%20Italy"},{"title3":"Coronavirus%20disease%202019%20(covid-19)%20in%20Italy"},{"title3":"Coronavirus%20disease%202019%20(covid-19)%20in%20Italy"},{"title3":"Coronavirus%20disease%202019%20(covid-19)%20in%20Italy"}]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy","References":[]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (covid-19) - United States, February 12-March 16, 2020","References":[{"title3":"Severe%20outcomes%20among%20patients%20with%20coronavirus%20disease%202019%20(covid-19)%20-%20United%20States,%20February%2012-March%2016,%202020"}]},{"title2":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020","References":[{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20-%20United%20States,%20February%2012-March%2028,%202020"},{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20-%20United%20States,%20February%2012-March%2028,%202020"},{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20-%20United%20States,%20February%2012-March%2028,%202020"},{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20-%20United%20States,%20February%2012-March%2028,%202020"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20covid-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (covid-19)","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(covid-19)"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020","References":[{"title3":"Analysis%20on%2054%20mortality%20cases%20of%20coronavirus%20disease%202019%20in%20the%20Republic%20of%20Korea%20from%20January%2019%20to%20March%2010,%202020"},{"title3":"Analysis%20on%2054%20mortality%20cases%20of%20coronavirus%20disease%202019%20in%20the%20Republic%20of%20Korea%20from%20January%2019%20to%20March%2010,%202020"}]},{"title2":"Covid-19 in critically ill patients in the Seattle Region - case series","References":[{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20Region%20-%20case%20series"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"NYC Health. Cases, hospitalizations and deaths. 2020. https://www1.nyc.gov/site/doh/covid/covid-19-data.page#download.","References":[]},{"title2":"Comparison of 3 Safety-Net Hospital Definitions and Association With Hospital Characteristics","References":[{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"},{"title3":"Comparison%20of%203%20Safety-Net%20Hospital%20Definitions%20and%20Association%20With%20Hospital%20Characteristics"}]},{"title2":"Generalized collinearity diagnostics","References":[]},{"title2":"Imdad MU, Aslam M. mctest: multicollinearity diagnostic measures version 1.2.5 2018. https://CRAN.R-project.org/package=mctest.","References":[]},{"title2":"A method for computing profile-likelihood based confidence intervals","References":[]},{"title2":"A proportional hazards model for the subdistribution of a competing risk","References":[]},{"title2":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","References":[]},{"title2":"Sfumato P. Goodness-of-fit for time-to-event data. 2020. https://www.rdocumentation.org/packages/goftte/versions/1.0.5.","References":[]},{"title2":"Melby C, Gu J, Rojanasakul M. Mapping New York City hospital beds as coronavirus cases surge. 2020 https://www.bloomberg.com/graphics/2020-new-york-coronavirus-outbreak-how-many-hospital-beds/.","References":[]},{"title2":"World Health Organization. Hospital beds (per 10 000 population). 2020 https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hospital-beds-(per-10-000-population).","References":[]},{"title2":"Incidence and outcomes of acute lung injury","References":[{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"},{"title3":"Incidence%20and%20outcomes%20of%20acute%20lung%20injury"}]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","References":[]},{"title2":"Sepsis and septic shock","References":[]},{"title2":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?","References":[]},{"title2":"The impact of influenza epidemics on hospitalizations","References":[]},{"title2":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008","References":[]},{"title2":"The pathophysiology and treatment of sepsis","References":[{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"},{"title3":"The%20pathophysiology%20and%20treatment%20of%20sepsis"}]},{"title2":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","References":[]},{"title2":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","References":[{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"},{"title3":"Complement%20associated%20microvascular%20injury%20and%20thrombosis%20in%20the%20pathogenesis%20of%20severe%20COVID-19%20infection:%20a%20report%20of%20five%20cases"}]},{"title2":"Inflammatory cytokines in general and central obesity and modulating effects of physical activity","References":[{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"},{"title3":"Inflammatory%20cytokines%20in%20general%20and%20central%20obesity%20and%20modulating%20effects%20of%20physical%20activity"}]},{"title2":"Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue","References":[{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"},{"title3":"Immune%20cell-derived%20cytokines%20contribute%20to%20obesity-related%20inflammation,%20fibrogenesis%20and%20metabolic%20deregulation%20in%20human%20adipose%20tissue"}]},{"title2":"Atherosclerosis and inflammation: overview and updates","References":[]},{"title2":"Report of the conference on low blood cholesterol: mortality associations","References":[]}]},{"title1":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19","References":[{"title2":"COVID-19: cases in the US. Atlanta: Centers for Disease Control and Prevention, 2020 ().","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China."}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy.","References":[]},{"title2":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020.","References":[{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20:%20United%20States,%20February%2012-March%2028,%202020."},{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20:%20United%20States,%20February%2012-March%2028,%202020."},{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20:%20United%20States,%20February%2012-March%2028,%202020."},{"title3":"Preliminary%20estimates%20of%20the%20prevalence%20of%20selected%20underlying%20health%20conditions%20among%20patients%20with%20coronavirus%20disease%202019%20:%20United%20States,%20February%2012-March%2028,%202020."}]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020.","References":[{"title3":"Severe%20outcomes%20among%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)%20:%20United%20States,%20February%2012-March%2016,%202020."}]},{"title2":"Geographic differences in COVID-19 cases, deaths, and incidence : United States, February 12-April 7, 2020.","References":[{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."},{"title3":"Geographic%20differences%20in%20COVID-19%20cases,%20deaths,%20and%20incidence%20:%20United%20States,%20February%2012-April%207,%202020."}]},{"title2":". COVID-19 home page ().","References":[]},{"title2":". QuickFacts: Louisiana ().","References":[]},{"title2":". Facts &amp; statistics ().","References":[{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."},{"title3":".%20Facts%20&amp;%20statistics%20()."}]},{"title2":". Uniform Data System Mapper ().","References":[]},{"title2":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","References":[]},{"title2":"How to measure comorbidity: a critical review of available methods.","References":[]},{"title2":"Association of patient social, cognitive, and functional risk factors with preventable hospitalizations: implications for physician value-based payment.","References":[]},{"title2":"Impact of overweight and obesity on hospitalization: race and gender differences.","References":[{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."},{"title3":"Impact%20of%20overweight%20and%20obesity%20on%20hospitalization:%20race%20and%20gender%20differences."}]},{"title2":"Multiple imputation of discrete and continuous data by fully conditional specification.","References":[]},{"title2":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis.","References":[]},{"title2":"Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 : Georgia, March 2020.","References":[{"title3":"Characteristics%20and%20clinical%20outcomes%20of%20adult%20patients%20hospitalized%20with%20COVID-19%20:%20Georgia,%20March%202020."},{"title3":"Characteristics%20and%20clinical%20outcomes%20of%20adult%20patients%20hospitalized%20with%20COVID-19%20:%20Georgia,%20March%202020."},{"title3":"Characteristics%20and%20clinical%20outcomes%20of%20adult%20patients%20hospitalized%20with%20COVID-19%20:%20Georgia,%20March%202020."},{"title3":"Characteristics%20and%20clinical%20outcomes%20of%20adult%20patients%20hospitalized%20with%20COVID-19%20:%20Georgia,%20March%202020."},{"title3":"Characteristics%20and%20clinical%20outcomes%20of%20adult%20patients%20hospitalized%20with%20COVID-19%20:%20Georgia,%20March%202020."}]},{"title2":". 2018 Louisiana health report card ().","References":[]},{"title2":"Covid-19 in critically ill patients in the Seattle region : case series.","References":[{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."},{"title3":"Covid-19%20in%20critically%20ill%20patients%20in%20the%20Seattle%20region%20:%20case%20series."}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","References":[]},{"title2":"Genetic ancestry and natural selection drive population differences in immune responses to pathogens.","References":[]},{"title2":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.","References":[]}]},{"title1":"Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19","References":[{"title2":"Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), Johns-Hopkins-University website. July 1, 2020.https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Accessed July 1, 2020.","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"ACC CLINICAL BULLETIN COVID-19 Clinical Guidance For the CV Care Team, American College of Cardiology website. February 07, 2020.https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/02/S20028-ACC-Clinical-Bulletin-Coronavirus.pdf. Accessed July 1, 2020.","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"CDC Diagnostic Test for COVID-19, Centers for Disease Control and Prevention website. June 2020.https://www.cdc.gov/coronavirus/2019-ncov/lab/testing.html. Accessed July 1, 2020.","References":[]},{"title2":"Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19. endorsed by the society of thoracic radiology, the American college of radiology, and RSNA","References":[{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"},{"title3":"Radiological%20society%20of%20North%20America%20expert%20consensus%20statement%20on%20reporting%20chest%20CT%20findings%20related%20to%20COVID-19.%20endorsed%20by%20the%20society%20of%20thoracic%20radiology,%20the%20American%20college%20of%20radiology,%20and%20RSNA"}]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"China medical treatment expert group for C. cmorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","References":[]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"}]},{"title2":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","References":[{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"},{"title3":"Angiotensin-converting%20enzyme%202%20(ACE2)%20is%20a%20key%20modulator%20of%20the%20renin%20angiotensin%20system%20in%20health%20and%20disease"}]},{"title2":"Clinical features and short-term outcomes of 144 patients with SARS in the greater toronto area","References":[]},{"title2":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","References":[{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"}]},{"title2":"Cardiac tamponade secondary to COVID-19","References":[{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"},{"title3":"Cardiac%20tamponade%20secondary%20to%20COVID-19"}]},{"title2":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights","References":[{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"},{"title3":"First%20case%20of%20COVID-19%20complicated%20with%20fulminant%20myocarditis:%20a%20case%20report%20and%20insights"}]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"High-sensitivity troponin T is an important independent predictor in addition to the simplified acute physiology score for short-term ICU mortality, particularly in patients with sepsis","References":[]},{"title2":"Myocardial injury in patients with sepsis and its association with long-term outcome","References":[]},{"title2":"High-sensitivity cardiac troponin T is an independent predictor of inhospital mortality in emergency department patients with suspected infection: a prospective observational derivation study","References":[]},{"title2":"The coagulopathy of acute sepsis","References":[{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"},{"title3":"The%20coagulopathy%20of%20acute%20sepsis"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal%20coagulation%20parameters%20are%20associated%20with%20poor%20prognosis%20in%20patients%20with%20novel%20coronavirus%20pneumonia"},{"title3":"Abnormal%20coagulation%20parameters%20are%20associated%20with%20poor%20prognosis%20in%20patients%20with%20novel%20coronavirus%20pneumonia"},{"title3":"Abnormal%20coagulation%20parameters%20are%20associated%20with%20poor%20prognosis%20in%20patients%20with%20novel%20coronavirus%20pneumonia"},{"title3":"Abnormal%20coagulation%20parameters%20are%20associated%20with%20poor%20prognosis%20in%20patients%20with%20novel%20coronavirus%20pneumonia"},{"title3":"Abnormal%20coagulation%20parameters%20are%20associated%20with%20poor%20prognosis%20in%20patients%20with%20novel%20coronavirus%20pneumonia"}]},{"title2":"Kawasaki-like disease: emerging complication during the COVID-19 pandemic","References":[{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"},{"title3":"Kawasaki-like%20disease:%20emerging%20complication%20during%20the%20COVID-19%20pandemic"}]},{"title2":"ST-Segment elevation in patients with covid-19 : a case series","References":[]}]},{"title1":"Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients","References":[{"title2":"World Health Organization. Coronavirus disease (COVID-19) Situation Report - 151. Available athttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200619-covid-19-sitrep-151.pdf?sfvrsn=8b23b56e_2 (Accessed on June 20, 2020).","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)"}]},{"title2":"Cardiac troponin I is an independent predictor for mortality in hospitalized patients with coronavirus disease 2019","References":[]},{"title2":"Demographics, comorbidities, and outcomes in hospitalized covid-19 patients in rural Southwest Georgia","References":[]},{"title2":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","References":[{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"},{"title3":"Prevalence%20and%20impact%20of%20myocardial%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20infection"}]},{"title2":"Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19","References":[{"title3":"Acute%20myocardial%20injury%20at%20hospital%20admission%20is%20associated%20with%20all-cause%20mortality%20in%20COVID-19"},{"title3":"Acute%20myocardial%20injury%20at%20hospital%20admission%20is%20associated%20with%20all-cause%20mortality%20in%20COVID-19"},{"title3":"Acute%20myocardial%20injury%20at%20hospital%20admission%20is%20associated%20with%20all-cause%20mortality%20in%20COVID-19"},{"title3":"Acute%20myocardial%20injury%20at%20hospital%20admission%20is%20associated%20with%20all-cause%20mortality%20in%20COVID-19"}]},{"title2":"Myocardial injury and COVID-19: possible mechanisms","References":[{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"},{"title3":"Myocardial%20injury%20and%20COVID-19:%20possible%20mechanisms"}]},{"title2":"COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors","References":[{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"},{"title3":"COVID-19%20cardiac%20injury:%20implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors"}]},{"title2":"Fourth universal definition of myocardial infarction (2018)","References":[{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"},{"title3":"Fourth%20universal%20definition%20of%20myocardial%20infarction%20(2018)"}]}]}]}